Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2017 Filed Mar 14, 2017 16:04 UTC |
HOWARD RUDYCFO & Secretary
|
GrantEmployee stock option (right to buy) · Derivative | 105,070 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001562180-17-001255 · primarydocument.xml · derivative · entry 1 HOWARD RUDY · CIK 0001108161 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,914 Underlying: Class A Common Stock · 105,070 shares Expires 2027-03-10 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 10, 2018. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 20:04 UTC |
KINDLER JEFFREY BDirector · Executive Chairman
|
GrantRestricted Stock Unit · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-001256 · primarydocument.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Class A Common Stock · 35,000 shares Expires 2020-03-10 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of vTv Therapeutics Inc. Class A common stock. F2 · derivative.exercise_date: Grant vests in three equal annual installments beginning on March 10, 2018. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 16:04 UTC |
ALTSTIEL LARRY DOUGLASChief Medical Officer
|
GrantEmployee stock option (right to buy) · Derivative | 128,085 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001562180-17-001253 · primarydocument.xml · derivative · entry 1 ALTSTIEL LARRY DOUGLAS · CIK 0001619444 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,085 Underlying: Class A Common Stock · 128,085 shares Expires 2027-03-10 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning March 10, 2018 Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 20:04 UTC |
Holcombe Stephen L.President & CEO
|
GrantEmployee stock option (right to buy) · Derivative | 165,110 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001562180-17-001254 · primarydocument.xml · derivative · entry 1 Holcombe Stephen L. · CIK 0001648953 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,579 Underlying: Class A Common Stock · 165,110 shares Expires 2027-03-10 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 10, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.